The Redwood City, Calif.-based company posted losses of $6.2 million, or 21¢ per share, on sales of $82.3 million for the 3 months ended September 30, seeing losses grow 60.3% while sales grew 35% compared with the same period during the prior fiscal year.
Losses per share were just below of expectations of 22¢ per share, where analysts were expecting to see sales of $80.5 million for the quarter, which the company also topped.
The company lifted its revenue expectations for the full year, expecting to see sales between $315 million and $320 million, up from previous expectations of between $310 million and $320 million, according to a press release.
Shares in Nevro have fallen 8.2% so far today, at $80.99 as of 1:00 p.m. EST.
In August, Nevro saw shares fall despite posting second-quarter revenues that came in well ahead of analysts’ expectations and just beat the company’s own forecast.